These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7791825)

  • 21. [Helicobacter pylori infection. The Spanish consensus report. The Spanish Consensus Conference Group].
    Sainz R; Borda F; Domínguez E; Gisbert JP
    Rev Esp Enferm Dig; 1999 Nov; 91(11):777-84. PubMed ID: 10601771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Helicobacter pylori infection.
    Suerbaum S; Michetti P
    N Engl J Med; 2002 Oct; 347(15):1175-86. PubMed ID: 12374879
    [No Abstract]   [Full Text] [Related]  

  • 23. [Modern policy of anti-helicobacter therapy of ulcer disease].
    Ryss ES
    Klin Med (Mosk); 1998; 76(10):7-11. PubMed ID: 9865008
    [No Abstract]   [Full Text] [Related]  

  • 24. Therapeutic approaches to recurrent peptic ulcer disease.
    Cave DR
    Hosp Pract (Off Ed); 1992 Sep; 27(9A):33-40, 43, 47-9. PubMed ID: 1522168
    [No Abstract]   [Full Text] [Related]  

  • 25. Antibacterial and ulcer healing effects of organoselenium compounds in naproxen induced and Helicobacter pylori infected Wistar rat model.
    Kumar BS; Tiwari SK; Saikant R; Manoj G; Kunwar A; Sivaram G; Abid Z; Ahmad A; Priyadarsini KI; Khan AA
    J Trace Elem Med Biol; 2010 Oct; 24(4):263-70. PubMed ID: 20678908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: prospective nonrandomized trial on 125 patients.
    Santander C; Grávalos RG; Gómez-Cedenilla A; Cantero J; Pajares JM
    Am J Gastroenterol; 1996 Aug; 91(8):1549-52. PubMed ID: 8759659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of Helicobacter pylori infection. Triple regimen based on ranitidine bismuth citrate could be solution.
    Savarino V; Neri M; Vigneri S
    BMJ; 2000 Jun; 320(7248):1541. PubMed ID: 10877585
    [No Abstract]   [Full Text] [Related]  

  • 28. [H. pylori eradication therapy compared with antisecretory non-eradication therapy for the prevention of recurrent bleeding stomach ulcer].
    Dam A; Schaffalitzky de Muckadell OB
    Ugeskr Laeger; 2005 Jan; 167(5):497-9. PubMed ID: 15745169
    [No Abstract]   [Full Text] [Related]  

  • 29. [Evidence-based management of gastroduodenal ulcer].
    Rodríguez Téllez M; Herrerías Esteban JM; Carmona Soria I; Herrerías Gutiérrez JM
    An Med Interna; 1998 Oct; 15(10):548-53. PubMed ID: 9844233
    [No Abstract]   [Full Text] [Related]  

  • 30. Peptic ulcer treatment today--is there a role for maintenance therapy?
    Breslin NP; O'Morain C
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):116-21. PubMed ID: 9646190
    [No Abstract]   [Full Text] [Related]  

  • 31. [Helicobacter pylori and chronic ulcer disease].
    Gustavsson S; Engstrand L
    Lakartidningen; 1991 Feb; 88(8):624-5. PubMed ID: 2002726
    [No Abstract]   [Full Text] [Related]  

  • 32. [Ulcer disease and gastritis in Helicobacter pylori infection].
    Gastroenterol Clin Biol; 1996 Jan; 20(1 Pt 2):S163-S165. PubMed ID: 8734385
    [No Abstract]   [Full Text] [Related]  

  • 33. Relapse of duodenal ulcers after successful eradication of Helicobacter pylori in gastric ulcer patients.
    Sou Y; Saita H; Takahashi Y; Yoshinaga T; Matsukawa Y; Sekikawa A; Nakazawa T; Shio S; Kohigashi K
    J Gastroenterol; 1999; 34 Suppl 11():84-90. PubMed ID: 10616773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy.
    Kung NN; Sung JJ; Yuen NW; Ng PW; Wong KC; Chung EC; Lim BH; Choi CH; Li TH; Ma HC; Kwok SP
    Am J Gastroenterol; 1997 Mar; 92(3):438-41. PubMed ID: 9068464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
    Avidan B; Melzer E; Keller N; Bar-Meir S
    Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-term eradication therapy for Helicobacter pylori does not reduce the incidence of gastric metaplasia in duodenal ulcer patients.
    Rudnicka L; Bobrzyński A; Stachura J
    Pol J Pathol; 1997; 48(2):103-6. PubMed ID: 9278106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New concepts concerning management of Helicobacter pylori infection: 2 years after the Maastricht Consensus Report.
    Gasbarrini G; Malfertheiner P; Deltenre M; Mégraud F; O'Morain C; Pajares-García J; Quina M; Bianchi Porro G; Gasbarrini A; Franceschi F; Armuzzi A; Cammarota G; Anti M; Pretolani S
    Ital J Gastroenterol Hepatol; 1998 Oct; 30 Suppl 3():S244-7. PubMed ID: 10077746
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro and in vivo anti-Helicobacter pylori activity of Calophyllum brasiliense Camb.
    Souza Mdo C; Beserra AM; Martins DC; Real VV; Santos RA; Rao VS; Silva RM; Martins DT
    J Ethnopharmacol; 2009 Jun; 123(3):452-8. PubMed ID: 19501278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Triple therapy and Helicobacter pylori.
    Davis S
    Aust Fam Physician; 1996 Jan; 25(1):53, 56-9. PubMed ID: 8607776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
    Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
    Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.